So true but calling Ignoramus "poli-sci journalist" is giving him way too much credit -- he's not good at any form of journalism but dabbling in this arena is way over his head and clearly one he's swimming in only for some personal gain b/c no one credible will do it.
"political science journalists like Adam Feuerstein are clueless when it comes to understanding Her2 expression and how it relates to breast cancer."
Her2 positive cancers are more aggressive and more likely to recur and GALENA offers one of the most commonly used often last-hope treatments. That's a terrifying diagnosis, to hear "your cancer has metastasized..." or is likely to.
Neuvax trials with and without Herceptin offer cutting-edge treatment and hope for the most difficult to treat cases. (Sadly, no known cure for Frog-Eyed Ignoramuses who failed both poli-sci and bio-tech pseudo-journalism, those cases are fatal.)
From the Dec. 11/14 report:
"Galena has two additional breast cancer trials ongoing with NeuVax in combination with Herceptin(R) (trastuzumab; Genentech/Roche): a Phase 2b in node positive and triple negative HER2 IHC 1+/2+, and a Phase 2 in neoadjuvant node positive & negative HER2 IHC 3+."
More about Herceptin:
There are some treatments available specifically for HER2-positive breast cancer. The most commonly used medication is Herceptin (chemical name: trastuzumab), which works by attaching itself to the HER2 receptors on breast cancer cells and blocking them from receiving growth signals. By blocking these signals, Herceptin may help to slow or even stop the growth of the breast cancer. In addition to blocking HER2 receptors, Herceptin can also help fight breast cancer by alerting the immune system to destroy cancer cells onto which it is attached.
Yes Harry Crumb, nice EOD rally pricewise but hope it keeps going up, after reaching year-lows this has a LONG way to go to recover. I do hope that Schwartz & Co. develop a bit more marketing savvy even as they're clearly determined to stay on the "high road" and avoid Ahn's mistakes -- a little PR/ marketing is always in order. Can't live in fear of Frog-eyes and his like, fight 'em with facts.
News 
Market Data 
Discover 
